| Cat.No. | Name | Information |
|---|---|---|
| M1973 | Ostarine | Ostarine (GTx-024 and MK-2866) is an investigational selective androgen receptor modulator (SARM) with Ki of 3.8 nM. |
| M5565 | Dexmedetomidine HCl | Dexmedetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is used in veterinary medicine for its analgesic and sedative properties. |
| M5805 | Nandrolone | Nandrolone is a synthetic, anabolic steroid analog of testosterone. |
| M1839 | MDV3100 | MDV3100 is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. |
| M5764 | Medroxyprogesterone acetate | Medroxyprogesterone acetate (MPA) is a synthetic progestin and act as a potent progesterone receptor agonist, used to treat abnormal menstruation or irregular vaginal bleeding. |
| M2270 | Apalutamide (ARN-509) | Apalutamide (ARN-509) is a novel androgen receptor (AR) antagonist for the treatment of castration-resistant prostate cancer (CRPC). |
| M10306 | Bavdegalutamide (ARV-110) | Bavdegalutamide (ARV-110) is an oral, specific androgen receptor (AR) PROTAC degrader. |
| M6121 | Testosterone phenylpropionate | Testosterone phenylpropionate is a synthetic anabolic-androgenic steroid (AAS) and an androgen ester. |
| M6120 | Testosterone isocaproate | Testosterone isocaproate is an androgen. |
| M6119 | Testosterone Enanthate | Androcur-treatment abolished testosterone-reduced cAMP, coupled with a changed expressional milieu of cAMP signaling elements. Results from in vitro experiments suggest that some of these effects are testosterone-AR dependent, while others could be due to disturbed LH and/or other signals. |
| M6117 | Testosterone decanoate | Testosterone decanoate is an androgen. |
| M6116 | Drostanolone Enanthate | Drostanolone is one of the most frequently detected anabolic androgenic steroids in doping control analysis. |
| M6115 | Drostanolone Propionate | Drostanolone propionate can reduce the uptake of oestradiol-17B by tumour cells |
| M6114 | Metandienone | Metandienone is a synthetic anabolic steroid that is prohibited in sports by the World Anti-Doping Agency (WADA). |
| M6106 | 17α-Methyltestosterone | 17α-Methyltestosterone has similar binding affinity to AR and similar androgenic and anabolic activities as testosterone. IC50 value: 17 nM (Ki) Target:Androgen Receptor. |
| M6099 | Boldenone Undecylenate | Boldenone undecylenate(Equipoise) is a synthetic steroid which has a similar effect as the natural steroid testosterone. |
| M5806 | Nandrolone decanoate | Nandrolone Decanoate is a mild form of an anabolic steroid. |
| M5778 | Methenolone acetate | Metenolone (Methenolone) is a long-acting anabolic steroid with weak androgenic properties. |
| M5659 | Flutamide | Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor with Ki values of 55 nM, and primarily used to treat prostate cancer. |
| M5657 | Fluoxymesterone | Fluoxymesterone is an Androgen. The mechanism of action of fluoxymesterone is as an Androgen Receptor Agonist. |
| M5586 | DL-Epinephrine | DL-Epinephrine(DL-Adrenaline) is a hormone and a neurotransmitter. |
| M5544 | Cyproterone Acetate | Cyproterone acetate is an androgen receptor (AR) antagonist with IC50 of 7.1 nM. |
| M5454 | Betaxolol hydrochloride | Betaxolol hydrochloride is a β1 adrenergic receptor blocker with IC50 of 6 μM. |
| M5396 | Alfuzosin HCl | Alfuzosin HCl is an alpha1 receptor antagonist used to treat benign prostatic hyperplasia (BPH). |
| M5395 | Alfuzosin | Alfuzosin is an α1 adrenergic receptor antagonist used to treat benign prostatic hyperplasia (BPH). |
| M5035 | Clascoterone | Clascoterone (Cortexolone 17α-propionate, CB-03-01) is a new selective androgen receptor (AR) antagonist. |
| M4703 | Lupeol | Lupeol (Clerodol; Monogynol B; Fagarasterol (Fagarasterol) is an active pentacyclic triterpenoid with antioxidant, anti-tumor and anti-inflammatory activities. Lupeol is a potent androgen receptor inhibitor that can be used in cancer research, especially in prostate cancer with androgen-dependent phenotypes (ADPC) and castration-resistant phenotypes (CRPC). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
